Recovery of alpha 2-adrenoceptor binding and function after irreversible inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
Recovery of alpha 2-adrenoceptor binding and function after irreversible inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
复制标题
N-乙氧基羰基-2-乙氧基-1,2-二氢喹啉 (EEDQ) 不可逆失活后,α2-肾上腺素受体结合和功能恢复。
DOI:
10.1016/0014-2999(85)90200-6
复制
发表时间:
1985
影响因子:
5
通讯作者:
Goldstein,M
中科院分区:
文献类型:
--
作者:
Adler,CH;Meller,E;Goldstein,M
Abstract Treatment of rats with N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ) resulted in a pronounced loss of α 2-adrenoceptor binding ([3 H] RX-781094) and a marked reduction in the ability of the α 2-agonist UK-14,304 to inhibit K+-stimulated release of both [3 H] NA and [3 H] 5-HT in cerebral cortex. Repopulation of α 2-anderoceptors was monoexponential with a t 1 2 of 4.1 days; functional recovery was also monoexponential, with t 1 2 values of 2.4 and 4.6 days for restoration of α 2-mediated inhibition of [3 H] NA and [3 H] 5-HT release, respectively. Other studies suggest the difference in functional recovery rate may reflect the presence of a large receptor reserve for autoreceptors relative to heteroreceptors.